Top Markets
Coin of the day
Synmosa Biopharma Corporation Synmosa Biopharma Corporation

Synmosa Biopharma Corporation

4114
Rangering i aksjer #13193
Synmosa Biopharma Corporation, established in Taipei, Taiwan, in 1980, operates... Synmosa Biopharma Corporation, established in Taipei, Taiwan, in 1980, operates as a dedicated specialty pharmaceutical enterprise. The company manages the entire lifecycle of pharmaceutical and healthcare products, from research and development to manufacturing, marketing, and distribution, primarily serving the Taiwanese market under its proprietary Synmosa brand. Its diverse product portfolio addresses key therapeutic categories, including cardiovascular health, respiratory conditions, urology, sex hormone treatments, and oncology. These offerings are available in various formats such as effervescent tablets, granules, nasal sprays, metered-dose inhalers, hormonal preparations, and other specialized forms. Beyond its proprietary products, Synmosa also extends its expertise through contract manufacturing services. The company maintains a significant international presence, exporting its goods to numerous countries including South Africa, China, Hong Kong, Thailand, Singapore, Malaysia, Vietnam, Myanmar, Cambodia, Peru, Costa Rica, and Nicaragua.
Aksjekurs
$0.94761103
Markedsverdi
$511.40M
Endring (1 dag)
-0.33%
Endring (1 år)
-9.95%
Land
TW
Handel Synmosa Biopharma Corporation (4114)

Kategori

Inntekter for Synmosa Biopharma Corporation (4114)
Inntekter i Aug 2026 TTM: 0
Ifølge de nyeste økonomiske rapportene til Synmosa Biopharma Corporation er selskapets nåværende inntekter (TTM) 0. I 2026 hadde selskapet inntekter på 0 lik inntektene i 2026, som var 0. Inntektene er det totale beløpet et selskap genererer fra salg av varer eller tjenester. I motsetning til fortjeneste trekkes ingen kostnader fra.
Inntektshistorikk for Synmosa Biopharma Corporation fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter